These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25037732)

  • 1. A method to evaluate the effect of contact with excipients on the surface crystallization of amorphous drugs.
    Zhang SW; Yu L; Huang J; Hussain MA; Derdour L; Qian F; de Villiers MM
    AAPS PharmSciTech; 2014 Dec; 15(6):1516-26. PubMed ID: 25037732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility of small-molecule crystals in polymers: D-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA.
    Tao J; Sun Y; Zhang GG; Yu L
    Pharm Res; 2009 Apr; 26(4):855-64. PubMed ID: 19052850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel formulation for solubility and content uniformity enhancement of poorly water-soluble drugs using highly-porous mannitol.
    Saffari M; Ebrahimi A; Langrish T
    Eur J Pharm Sci; 2016 Feb; 83():52-61. PubMed ID: 26687442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatin Nano-coating for Inhibiting Surface Crystallization of Amorphous Drugs.
    Teerakapibal R; Gui Y; Yu L
    Pharm Res; 2018 Jan; 35(1):23. PubMed ID: 29305725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roller compaction, granulation and capsule product dissolution of drug formulations containing a lactose or mannitol filler, starch, and talc.
    Chang CK; Alvarez-Nunez FA; Rinella JV; Magnusson LE; Sueda K
    AAPS PharmSciTech; 2008; 9(2):597-604. PubMed ID: 18459052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compression-induced crystallization of amorphous indomethacin in tablets: characterization of spatial heterogeneity by two-dimensional X-ray diffractometry.
    Thakral NK; Mohapatra S; Stephenson GA; Suryanarayanan R
    Mol Pharm; 2015 Jan; 12(1):253-63. PubMed ID: 25438193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of powder and tableting properties of low and high degree of polymerization cellulose I and cellulose II excipients.
    de la Luz Reus Medina M; Kumar V
    Int J Pharm; 2007 Jun; 337(1-2):202-9. PubMed ID: 17376616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of spray-dried mannitol on the performance of microcrystalline cellulose-based wet granulated tablet formulation.
    Badawy SI; Shah KR; Surapaneni MS; Szemraj MM; Hussain M
    Pharm Dev Technol; 2010; 15(4):339-45. PubMed ID: 20088677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of low levels of amorphous content in inhalation grade lactose by moisture sorption isotherms.
    Vollenbroek J; Hebbink GA; Ziffels S; Steckel H
    Int J Pharm; 2010 Aug; 395(1-2):62-70. PubMed ID: 20493937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of diluents on the compaction, dissolution, and physical stability of amorphous solid dispersion tablets.
    Yu D; Hoag SW
    Int J Pharm; 2024 Apr; 654():123924. PubMed ID: 38395318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative Humidity Cycling: Implications on the Stability of Moisture-Sensitive Drugs in Solid Pharmaceutical Products.
    Veronica N; Heng PWS; Liew CV
    Mol Pharm; 2023 Feb; 20(2):1072-1085. PubMed ID: 36480246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of micronized poloxamers as lubricants in direct compression of tablets.
    Muzíková J; Vyhlídalová B; Pekárek T
    Acta Pol Pharm; 2013; 70(6):1087-96. PubMed ID: 24383332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.
    Ojarinta R; Saarinen J; Strachan CJ; Korhonen O; Laitinen R
    Eur J Pharm Biopharm; 2018 Nov; 132():112-126. PubMed ID: 30248394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of atomic force microscopy for determining crystal growth rates of nifedipine at the surface of amorphous solids with and without polymers.
    Miyazaki T; Aso Y; Kawanishi T
    J Pharm Sci; 2011 Oct; 100(10):4413-20. PubMed ID: 21541940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of properties of tablets and energy profile of compaction of two spray-dried lactoses.
    Muzíková J; Sináglová P
    Acta Pol Pharm; 2013; 70(1):129-35. PubMed ID: 23610968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials.
    Faqih AM; Mehrotra A; Hammond SV; Muzzio FJ
    Int J Pharm; 2007 May; 336(2):338-45. PubMed ID: 17289312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of a new co-processed dry binder based on spray-dried lactose and microcrystalline cellulose.
    Mužíková J; Sináglová P
    Ceska Slov Farm; 2013 Jun; 62(3):127-31. PubMed ID: 23961814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel sugar coating method for moisture protective tablets.
    Ando M; Ito R; Ozeki Y; Nakayama Y; Nabeshima T
    Int J Pharm; 2007 May; 336(2):319-28. PubMed ID: 17258875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.